Cargando…
Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing
PTEN is among the most commonly mutated tumor suppressor genes in human cancer. However, studying the role of PTEN in the pathogenesis of cancer has been limited, in part, by the paucity of human cell-based isogenic systems that faithfully model PTEN loss. In an effort to remedy this problem, gene e...
Autores principales: | Hill, Victoria K., Kim, Jung-Sik, James, C. David, Waldman, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413031/ https://www.ncbi.nlm.nih.gov/pubmed/28464039 http://dx.doi.org/10.1371/journal.pone.0176683 |
Ejemplares similares
-
Tyrosine-mutated AAV2-mediated shRNA silencing of PTEN promotes axon regeneration of adult optic nerve
por: Huang, ZhengRu, et al.
Publicado: (2017) -
rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021) -
Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice
por: Nishiguchi, Koji M., et al.
Publicado: (2020) -
Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
por: Li, Hui-Fang, et al.
Publicado: (2009) -
Computational and molecular tools for scalable rAAV-mediated genome editing
por: Stoimenov, Ivaylo, et al.
Publicado: (2015)